Financhill
Back

Synopsys Quote, Financials, Valuation and Earnings

Synopsys Price Quote

$460.32
-0.13 (0.31%)
(Updated: September 2, 2023 at 6:21 AM ET)

Synopsys Key Stats

Buy
53
Synopsys (SNPS) is a Buy

Day range:
$456.83 - $462.96
52-week range:
$267.00 - $468.03
Dividend yield:
0%
P/E ratio:
73.20
P/S ratio:
12.93
P/B ratio:
11.75%

Volume:
469.9K
Avg. volume:
695.4K
1-year change:
38.49%
Market cap:
$70B
Revenue:
$5.1B
EPS:
$6.67

How Much Does Synopsys Make?

  • How Much Are Synopsys's Sales Annually?
    SNPS Revenues are $5.1B
  • How Much Profit Does Synopsys's Make A Year?
    SNPS net income is $984.6M

Is Synopsys Growing As A Company?

  • What Is Synopsys's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.19%
  • What Is Synopsys's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.52%

Synopsys Stock Price Performance

  • Did Synopsys Stock Go Up Last Month?
    Synopsys share price went up by 1.53% last month
  • Did SNPS's Share Price Rise Over The Last Year?
    SNPS share price rose by 38.49% over the past 1 year

What Is Synopsys 52-Week High & Low?

  • What Is Synopsys’s 52-Week High Share Price?
    Synopsys has traded as high as $468.03 over the past 52 weeks
  • What Is Synopsys’s 52-Week Low Share Price?
    Synopsys has traded as low as $267.00 over the past 52 weeks

Synopsys Price To Free Cash Flow

  • Is Synopsys Stock Overvalued?
    Synopsys is trading at a price to free cash flow ratio of 44.74
  • Is Synopsys Stock Undervalued?
    Synopsys EV to Free Cash Flow ratio is 42.72
  • What Is Synopsys’s Price Earnings Growth Ratio?
    SNPS PEG ratio is 56.87
  • Is Synopsys Trading At A Premium To Earnings?
    Synopsys EV to EBIT ratio is 61.74

Is It Risky To Buy Synopsys?

  • How Much Debt Does Synopsys Have?
    Total long term debt quarterly is $18.2M
  • How Much Cash Does Synopsys Have?
    Cash and short term investments quarterly total is $1.8B
  • What Is Synopsys’s Book Value Per Share?
    Book value per share is 39.17

Is Synopsys Cash Flow Positive?

  • What Is SNPS Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.8B
  • What Is Synopsys’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.2B
  • What Is Synopsys’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$222.8M

Synopsys Return On Invested Capital

  • Is Management Doing A Good Job?
    SNPS return on invested capital is 17.92%
  • What Is Synopsys Return On Assets?
    ROA measures how assets are converting to revenues and is 10.77%
  • What Is SNPS Return On Equity?
    ROE is a measure of profitability and is 18.11%

Synopsys Earnings Date & Stock Price

  • What Is Synopsys's Stock Price Today?
    A single share of SNPS can be purchased today for 460.45
  • What Is Synopsys’s Stock Symbol?
    Synopsys trades on the nasdaq under the ticker symbol: SNPS
  • When Is Synopsys’s Next Earnings Date?
    The next quarterly earnings date for Synopsys is scheduled on November 30, 2023
  • When Is SNPS's next ex-dividend date?
    Synopsys's next ex-dividend date is June 24, 2020
  • How To Buy Synopsys Stock?
    You can buy Synopsys shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Synopsys Competitors

  • Who Are Synopsys's Competitors?
    Below is a list of companies who compete with Synopsys or are related in some way:
    • Adobe Inc (ADBE)
    • Autodesk Inc (ADSK)
    • Cadence Design Systems Inc (CDNS)
    • Salesforce Inc (CRM)
    • Microsoft Corp (MSFT)

Synopsys Dividend Yield

Data Unavailable

Synopsys Analyst Estimates

YoY Growth Past Surprise
EPS: 51.75% 5.25%
Revenue: 19.2% 0.3%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 484.64
Upside from Last Price: 5.25%

Major Shareholders

  • How many SNPS shares are owned by institutional investors?
    217.1M SNPS shares are owned by institutional investors
  • How many SNPS shares are owned by insiders?
    880.7K SNPS shares are owned by insiders